Actively Recruiting
Implicit and Explicit Assessment of Suicide Risk
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-05-29
108
Participants Needed
1
Research Sites
183 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire, Amiens
Lead Sponsor
C
Centre Hospitalier Pinel d'Amiens
Collaborating Sponsor
AI-Summary
What this Trial Is About
In 2007 Nock \& Banaji developed a so-called implicit suicide risk measurement using a computer tool: the Implicit Association Test (IAT). This measurement, associated with traditional evaluations, makes it possible to better predict suicidal recurrence. In 2020, the Poitiers team of Tello was able to replicate these results on a French population. However, although a high IAT score predicts the onset of suicide at 1 year, there is no data on how this score changes over time nor even data concerning the measure's ability to differentiate a population with explicit suicidal ideation from a population without explicit suicidal ideation. The investigators therefore seek to demonstrate an evolution of implicit suicidal ideation over time by replicating the measurement at inclusion, at 6 months and at 12 months, for different patient profiles: Suicidal ideation vs No suicidal ideation and suicide attempt vs no suicide attempt. Patients will be recruited from the emergency-unit of CHU Amiens-Picardie and will take the suicide-IAT as well as various questionnaires.
CONDITIONS
Official Title
Implicit and Explicit Assessment of Suicide Risk
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presenting to emergency for psychiatric reasons
- Adult person
- Signed free and informed consent
- Fluent in speaking and writing French
You will not qualify if you...
- Neurological disorders or major cognitive deterioration with confusion
- Acute psychotic decompensation
- Troubled acute behavior
- Intoxication with toxic substances or drugs impairing cognitive functions during assessment
- Adult under protective measure
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Universitaire d'Amiens
Amiens, Picardie, France, 80000
Actively Recruiting
Research Team
J
Jérôme Thilliez, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here